# Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma

> **NCT00456716** · PHASE2 · COMPLETED · sponsor: **Swedish Medical Center** · enrollment: 5 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** sorafenib

## Key facts

- **NCT ID:** NCT00456716
- **Lead sponsor:** Swedish Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2010-03-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00456716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00456716, "Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00456716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*